menu
    • menu

    Company profile for ADMA Biologics

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart. Our goal is to be a leader in developing and commercializing specialized, targeted, plasma-derived therapeutics to extend and enhance the ...
    ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart. Our goal is to be a leader in developing and commercializing specialized, targeted, plasma-derived therapeutics to extend and enhance the lives of individuals who are naturally or medically immunocompromised.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ADMA BiologicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    465 Route 17 South Ramsey, NJ 07446
    Telephone
    Telephone
    201 478 5552
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.admabiologics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ADMA Bio Reports Q1 2026 Financials And Business Update
    ADMA Bio Reports Q1 2026 Financials And Business Update

    06 May 2026

    // FIRSTWORD PHARMA

    https://www.globenewswire.com/news-release/2026/05/06/3289333/33130/en/adma-biologics-reports-first-quarter-2026-financial-results-and-provides-business-update.html

    FIRSTWORD PHARMA
    06 May 2026
    Share Share
    ADMA Bio Announces FDA Approval to Expand the Label for ASCENIV
    ADMA Bio Announces FDA Approval to Expand the Label for ASCENIV

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286563/33130/en/adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    ADMA Biologics To Report First Quarter 2026 Financial Results
    ADMA Biologics To Report First Quarter 2026 Financial Results

    29 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/29/3283611/33130/en/adma-biologics-to-report-first-quarter-2026-financial-results-on-may-6-2026.html

    GLOBENEWSWIRE
    29 Apr 2026
    Share Share
    ADMA Biologics Faces Fraud Probe After 29% Stock Plunge
    ADMA Biologics Faces Fraud Probe After 29% Stock Plunge

    09 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-09/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-secur

    PHARMIWEB
    09 Apr 2026
    Share Share
    ADMA Refutes Misleading Allegations By Culper Research
    ADMA Refutes Misleading Allegations By Culper Research

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263678/33130/en/ADMA-Biologics-Issues-Statement-Refuting-Unsubstantiated-Misleading-and-Inaccurate-Allegations-by-Culper-Research.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    BFA Law Investigates ADMA Biologics Following Short Seller Report
    BFA Law Investigates ADMA Biologics Following Short Seller Report

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/adma-breaking-investigation-bfa-law-launches-investigation-into-adma-biologics-after-short-seller-r

    PHARMIWEB
    26 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search